

Instance: composition-en-061484b9147260e88c643074459451f5
InstanceOf: CompositionUvEpi
Title: "Composition for cresemba Package Leaflet"
Description:  "Composition for cresemba Package Leaflet"
Usage: #example

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - cresemba"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Cresemba is and what it is used for </li>
<li>What you need to know before you use Cresemba</li>
<li>How to use Cresemba</li>
<li>Possible side effects </li>
<li>How to store Cresemba</li>
<li>Contents of the pack and other information</li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What cresemba is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What cresemba is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Cresemba is
Cresemba is an anti-fungal medicine that contains the active substance isavuconazole. 
How Cresemba works
Isavuconazole works by killing or stopping the growth of the fungus, which causes the infection. 
What Cresemba is used for
Cresemba is used in adults to treat the following fungal infections:
-
invasive aspergillosis, caused by a fungus in the  Aspergillus  group; 
-
mucormycosis, caused by a fungus belonging to the  Mucorales  group in patients for whom a 
treatment with amphotericin B is not appropriate.</p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take cresemba"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take cresemba"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2>Do not use Cresemba:</h2>
<p>if you are allergic to isavuconazole or any of the other ingredients of this medicine (listed in 
section 6),
-
if you have a heart beat problem called  familial short QT syndrome ,
-
if you are using any of the following medicines:
-
ketoconazole, used for fungal infections,
-
high doses of ritonavir (more than 200 mg every 12 hours), used for HIV,
-
rifampicin, rifabutin, used for tuberculosis,
-
carbamazepine, used for epilepsy,
-
barbiturate medicines like phenobarbital, used for epilepsy and sleep disorders,
-
phenytoin, used for epilepsy,
-
St John s wort, a herbal medicine used for depression,
-
efavirenz, etravirine, used for HIV,
-
nafcillin, used for bacterial infections.
Warnings and precautions 
Talk to your doctor, pharmacist or nurse before using Cresemba:
-
if you have had an allergic reaction to other  azole  anti-fungal treatments in the past, such as 
ketoconazole, fluconazole, itraconazole, voriconazole or posaconazole,
-
if you are suffering from severe liver disease. Your doctor should monitor you for possible side 
effects.
Look out for side effects
Stop using Cresemba and tell your doctor straight away if you notice any of the following 
side effects:
-
sudden wheezing, difficulty breathing, swelling of the face, lips, mouth or tongue, severe 
itching, sweating, dizziness or fainting, fast heartbeat or pounding in the chest   these 
may be signs of a severe allergic reaction (anaphylaxis).
Problems while having Cresemba as drip into a vein
Tell your doctor straight away if you notice any of the following side effects:
-
low blood pressure, feel short of breath, nausea, dizziness, headache, tingling   your doctor 
may decide to stop the infusion.
Changes in your liver function
Cresemba can sometimes affect your liver function. Your doctor may carry out blood tests while 
you are taking this medicine. 
Skin problems
Tell your doctor straight away if you get severe blistering of the skin, mouth, eyes or genitals.
Children and adolescents
Cresemba should not be used in children or adolescents younger than 18 years because there is no 
information on use in this age group.
Other medicines and Cresemba
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. 
Some medicines may affect the way Cresemba works or Cresemba may affect the way they work, if 
they are taken at the same time.
In particular, do not take this medicine and tell your doctor or pharmacist if you are taking any of the 
following medicines:
-
ketoconazole, used for fungal infections,
-
high doses of ritonavir (more than 200 mg every 12 hours), used for HIV,
-
rifampicin, rifabutin, used for tuberculosis,
-
carbamazepine, used for epilepsy,
-
barbiturate medicines like phenobarbital, used for epilepsy and sleep disorders,
-
phenytoin, used for epilepsy,
-
St John s wort, a herbal medicine used for depression,
-
efavirenz, etravirine, used for HIV,
-
nafcillin, used for bacterial infections.
Unless your doctor tells you otherwise, do not take this medicine and tell your doctor or pharmacist if 
you are taking any of the following medicines: 
-
rufinamide or other medicines which decrease the QT interval on the heart tracing (ECG),
-
aprepitant, used to prevent nausea and vomiting by cancer treatment, 
-
prednisone, used for rheumatoid arthritis,
-
pioglitazone, used for diabetes.
Tell your doctor or pharmacist if you are taking any of the following medicines, as a dose adjustment 
or monitoring may be required to check that the medicines are still having the desired effect: 
-
ciclosporin, tacrolimus and sirolimus, used to prevent rejection of a transplant,
-
cyclophosphamide, used for cancer,
-
digoxin, used to treat heart failure or an uneven heart beat,
-
colchicine, used for gout attack,
-
dabigatran etexilate, used to stop blood clots after hip or knee replacement surgery,
-
clarithromycin, used for bacterial infections,
-
saquinavir, fosamprenavir, indinavir, nevirapine, lopinavir/ritonavir combination, used for HIV,
-
alfentanil, fentanyl, used against strong pain,
-
vincristine, vinblastine, used for cancer,
-
mycophenolate mofetil (MMF), used in transplant patients,
-
midazolam, used for severe insomnia and stress,
-
bupropion, used for depression,
-
metformin, used for diabetes,
-
daunorubicin, doxorubicin, imatinib, irinotecan, lapatinib, mitoxantrone, topotecan, used for 
different sorts of cancer.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor for advice before using this medicine.
Do not take Cresemba if you are pregnant, unless your doctor tells you otherwise. This is because it is 
not known if it may affect or harm your unborn baby. 
Do not breast-feed if you are taking Cresemba. 
Driving and using machines
Cresemba may make you feel confused, tired or sleepy. It can also make you pass out. Therefore, be 
very careful when driving or operating machines.</p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take cresemba"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take cresemba"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Cresemba will be given to you by a doctor or nurse.
Starting dose for the first two days (48 hours)
The recommended dose is one vial every 8 hours.
Usual dose after the first two days
This is started 12 to 24 hours after your last starting dose. The recommended dose is one vial once a 
day.
You will be given this dose until your doctor tells you otherwise. The duration of treatment with 
Cresemba may be longer than 6 months if your doctor considers this necessary.
The vial will be given as a drip into a vein by your doctor or nurse.
If you use more Cresemba than you should
If you think you have been given too much Cresemba, talk to your doctor or nurse straight away. You 
may have more side effects such as: 
-
headache, feeling dizzy, restless or sleepy,
-
tingling, reduced sense of touch or sensation in the mouth,
-
problems being aware of things, hot flushes, anxiety, joint pain,
-
changes in the way things taste, dry mouth, diarrhoea, vomiting,
-
feeling your heart beat, faster heart rate, being more sensitive to light.
If you forget to use Cresemba
As you will be given this medicine under close medical supervision, it is unlikely that a dose would be 
missed. However, tell your doctor or nurse if you think that a dose has been forgotten.
If you stop using Cresemba
Cresemba treatment will continue for as long as your doctor tells you. This is to make sure that the 
fungal infection has gone.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop using Cresemba and tell your doctor straight away if you notice any of the following side 
effects:
-
a severe allergic reaction (anaphylaxis) such as sudden wheezing, breathing problems, 
swelling of the face, lips, mouth or tongue, severe itching, sweating, dizziness or fainting, fast 
heartbeat or pounding in the chest. 
Tell your doctor straight away if you notice any of the following side effects:
-
severe blistering of the skin, mouth, eyes or genitals.
Other side effects
Tell your doctor, pharmacist or nurse if you notice any of the following side effects:
Common: may affect up to 1 in 10 people
-
low potassium in your blood,
-
decreased appetite,
-
hallucinations (delirium),
-
headache,
-
sleepiness,
-
inflamed veins that could lead to blood clots,
-
shortness of breath or sudden and severe difficulty breathing,
-
feeling sick (nausea), being sick (vomiting), diarrhoea, stomach pain,
-
changes in blood tests of liver function,
-
rash, itching, 
-
kidney failure (symptoms could include swelling of legs),
-
chest pain, feeling tired or sleepy,
-
problems where the injection was given.
Uncommon: may affect up to 1 in 100 people
-
reduced white blood cells - can increase your risk of infection and fever,
-
reduced blood cells called  platelets  - can increase your risk for bleeding or bruising,
-
reduced red blood cells - can make you feel weak or short of breath or make your skin pale,
-
severe reduction in blood cells - can make you feel weak, cause bruising or make infections 
more likely,
-
rash, swelling of your lips, mouth, tongue or throat with difficulty breathing (hypersensitivity),
-
low blood sugar levels,
-
low blood levels of magnesium,
-
low levels in the blood of a protein called  albumin ,
-
not getting the right goodness from your diet (malnutrition),
-
depression, difficulty sleeping,
-
seizure, fainting or feeling faint, dizziness,
-
sensation of tingling, tickling, or pricking of the skin (paraesthesia),
-
altered mental state (encephalopathy), 
-
changes in taste (dysgeusia), 
-
feeling of  spinning  or being dizzy (vertigo),
-
heart beat problems - may be too fast or uneven, or extra heart beats   this may show in your 
heart tracing (electrocardiogram or ECG),
-
problems with the blood circulation,
-
low blood pressure,
-
wheezing, very fast breathing, coughing up blood or blood-stained sputum, nose bleeding,
-
indigestion,
-
constipation,
-
feeling bloated (abdominal distension),
-
enlarged liver,
-
inflammation of the liver,
-
problems with the skin, red or purple spots on the skin (petechiae), inflamed skin (dermatitis), 
hair loss, 
-
back pain,
-
swelling of the extremities,
-
feeling weak, very tired, or sleepy or generally out of sorts (malaise).
Side effects with frequency not known:
-
anaphylaxis (a severe allergic reaction).
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on the 
safety of this medicine.</p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store cresemba"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store cresemba"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date 
refers to the last day of that month.
Store in a refrigerator (2 C to 8 C).
Do not throw away any medicines via wastewater. Ask your pharmacist how to throw away medicines 
you no longer use. These measures will help protect the environment.</p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2>What Cresemba contains</h2>
<p>The active substance is isavuconazole. Each vial contains 372.6 mg isavuconazonium sulfate, 
corresponding to 200 mg isavuconazole.
-
The other ingredients (excipients) are mannitol (E421) and sulfuric acid.
What Cresemba looks like and contents of the pack
Cresemba 200 mg is presented in a single use glass vial as a powder for concentrate for solution for 
infusion.
Marketing Authorisation Holder:
Basilea Pharmaceutica Deutschland GmbH
Marie-Curie-Strasse 8
79539 L rrach
Germany
Manufacturer:
Almac Pharma Services (Ireland) Limited
Finnabair Industrial Estate
Dundalk, Co. Louth
A91 P9KD
Ireland
Almac Pharma Services Limited
Seagoe Industrial Estate
Craigavon, Co. Armagh
BT63 5UA
United Kingdom (Northern Ireland)
For any information about this medicine, please contact the local representative of the Marketing
Authorisation Holder:
Belgi /Belgique/Belgien
Pfizer SA/NV 
Tel/T l: +32 (0)2 554 62 Lietuva 
Pfizer Luxembourg SARL filialas Lietuvoje
Tel. +3705 2514 
     ,  <br />
 .: +359 2 970 4Luxembourg/Luxemburg
Pfizer SA/NV
T l/Tel: +32 (0)2 554 62  esk  republika
Pfizer s.r.o.
Tel: +420-283-004-Magyarorsz g
Pfizer Kft.
Tel.: + 36 1 488 37 Danmark
Unimedic Pharma AB
Tlf: +46 (0) 10-130 99 Malta
Vivian Corporation Ltd.
Tel: +35621 344Deutschland
PFIZER PHARMA GmbH
Tel: +49 (0)30 550055-51Nederland
Pfizer bv
Tel: +31 (0)800 63 34 Eesti
Pfizer Luxembourg SARL Eesti filiaal
Tel: +372 666 7Norge
Unimedic Pharma AB
Tlf: +46 (0) 10-130 99<br />
Pfizer    A.E.
 : +30 210 67 85  sterreich
Pfizer Corporation Austria Ges.m.b.H.
Tel: +43 (0)1 521 15-0
Espa a
Pfizer S.L.
Tel: +34 91 490 99 Polska
Pfizer Polska Sp. z o.o.
Tel.: +48 22 335 61 France
Pfizer 
T l: +33 (0)1 58 07 34 Portugal
Laborat rios Pfizer, Lda.
Tel: +351 21 423 5Hrvatska
Pfizer Croatia d.o.o. 
Tel: +385 1 3908 Rom nia 
Pfizer Rom nia S.R.L.
Tel: +40 (0) 21 20 728 Ireland
Pfizer Healthcare Ireland 
Tel: +1800 633 363 (toll free) 
+44 (0)1304 616Slovenija
Pfizer Luxembourg SARL
Pfizer, podru nica za svetovanje s podro ja
farmacevtske dejavnosti, Ljubljana
Tel: + 386 (0) 1 52 11  sland
Unimedic Pharma AB
S mi: +46 (0) 10-130 99 Slovensk  republika
Pfizer Luxembourg SARL, organiza n  zlo ka
Tel: +421-2-3355 5Italia
Pfizer S.r.l.
Tel: +39 06 33 18 Suomi/Finland
Unimedic Pharma AB
Puh/Tel: +46 (0) 10-130 99<br />
Pfizer    . . (CYPRUS BRANCH)
 : +357 22 817Sverige
Unimedic Pharma AB
Tel: +46 (0) 10-130 99 Latvija
Pfizer Luxembourg SARL fili le Latvij 
Tel: +371 670 35 United Kingdom (Northern Ireland)
Pfizer Limited
Tel: +44 (0)1304 616This leaflet was last revised in 
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

